U.S. flag

An official website of the United States government

NM_004715.5(CTDP1):c.863+389C>T AND Congenital cataracts-facial dysmorphism-neuropathy syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Oct 1, 2004
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000005622.4

Allele description [Variation Report for NM_004715.5(CTDP1):c.863+389C>T]

NM_004715.5(CTDP1):c.863+389C>T

Gene:
CTDP1:CTD phosphatase subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q23
Genomic location:
Preferred name:
NM_004715.5(CTDP1):c.863+389C>T
HGVS:
  • NC_000018.10:g.79710825C>T
  • NG_007988.1:g.36025C>T
  • NM_001202504.1:c.506+389C>T
  • NM_001318511.2:c.863+389C>T
  • NM_004715.4(CTDP1):c.863+389C>T
  • NM_004715.5:c.863+389C>TMANE SELECT
  • NM_048368.4:c.863+389C>T
  • LRG_236t1:c.863+389C>T
  • LRG_236:g.36025C>T
  • NC_000018.9:g.77470825C>T
  • NM_004715.3:c.863+389C>T
  • NM_004715.4:c.863+389C>T
Nucleotide change:
IVS6, C-T, +389
Links:
OMIM: 604927.0001; dbSNP: rs113994102
NCBI 1000 Genomes Browser:
rs113994102
Molecular consequence:
  • NM_001202504.1:c.506+389C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001318511.2:c.863+389C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_004715.5:c.863+389C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_048368.4:c.863+389C>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Congenital cataracts-facial dysmorphism-neuropathy syndrome (CCFDN)
Synonyms:
CATARACT, CONGENITAL, WITH FACIAL DYSMORPHISM AND NEUROPATHY; Congenital Cataracts, Facial Dysmorphism, and Neuropathy
Identifiers:
MONDO: MONDO:0011402; MedGen: C1858726; Orphanet: 48431; OMIM: 604168

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000025804OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 2004)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000041120GeneReviews
no classification provided
not providedunknownliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownnot providednot providednot providednot providednot providednot providedliterature only
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome.

Varon R, Gooding R, Steglich C, Marns L, Tang H, Angelicheva D, Yong KK, Ambrugger P, Reinhold A, Morar B, Baas F, Kwa M, Tournev I, Guerguelcheva V, Kremensky I, Lochmüller H, Müllner-Eidenböck A, Merlini L, Neumann L, Bürger J, Walter M, Swoboda K, et al.

Nat Genet. 2003 Oct;35(2):185-9. Epub 2003 Sep 21.

PubMed [citation]
PMID:
14517542

Mutation history of the roma/gypsies.

Morar B, Gresham D, Angelicheva D, Tournev I, Gooding R, Guergueltcheva V, Schmidt C, Abicht A, Lochmuller H, Tordai A, Kalmar L, Nagy M, Karcagi V, Jeanpierre M, Herczegfalvi A, Beeson D, Venkataraman V, Warwick Carter K, Reeve J, de Pablo R, Kucinskas V, Kalaydjieva L.

Am J Hum Genet. 2004 Oct;75(4):596-609. Epub 2004 Aug 20.

PubMed [citation]
PMID:
15322984
PMCID:
PMC1182047
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000025804.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In Rudari Vlax Roma (Gypsies) with congenital cataracts with facial dysmorphism and neuropathy (CCFDN; 604168), Varon et al. (2003) found perfect segregation of the disease phenotype with a C-to-T transition in an antisense Alu element in intron 6 of the CTDP1 gene (IVS6+389C-T). Screening of 887 unaffected population controls found a 6.9% carrier rate among the Rudari, in close agreement with predictions based on CCFDN prevalence; an average carrier rate of 0.6% in other Gypsy populations; and a rate of 0.0% among non-Gypsy Europeans. RT-PCR and sequencing analysis identified a rare mechanism of aberrant splicing in which the donor site created by the C-T transition activates an upstream cryptic acceptor site, resulting in the insertion of 95 nucleotides of the Alu sequence in the processed CTDP1 mRNA. This mechanism had been identified previously only in ornithine aminotransferase deficiency (258870.0023). The insertion in the CTDP1 mRNA results in a premature termination signal 17 codons downstream of exon 6, with the mutant transcript expected to undergo nonsense-mediated decay or lead to a nonfunctional protein lacking the nuclear localization signal. Varon et al. (2003) observed an abnormal product in all cell types studied, regardless of their involvement in the clinical phenotype.

Morar et al. (2004) used the IVS6+389C-T mutation and 4 other private mutations among the Roma (Gypsies) to infer some of the missing parameters relevant to the comprehensive characterization of the population history of the Gypsies. Sharing of mutations and high carrier rates supported a strong founder effect.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000041120.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot providednot providednot providedAssert pathogenicitynot providednot providednot providednot provided

Last Updated: May 12, 2024